Novo CEO pressed by Senate to cut selling prices of obesity, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the organization would take into account new talks with insurers about the checklist costs of Wegovy and copyright should they pledge to keep the medicines on their own formularies. The offer https://ayahealthcareaddress61605.blogoxo.com/30798538/5-simple-techniques-for-healthcare-news